Literature DB >> 687503

Quantitative determination of ergot alkaloids in biological fluids by radioimmunoassay.

T T Kleimola.   

Abstract

1 Cross-reactivity of ergot alkaloids with an antiserum produced against lysergic acid conjugated with human serum, albumin was utilized to develop a radioimmunoassay for ergotamine, dihydroergotamine, dihydroergotoxine, ergometrine and methylergometrine in biological fluids. The antisera showed no cross-reactivity with simpler indole structures. 2 A procedure for extraction and concentration of alkaloids in biological fluids was developed. 3 The assay is sensitive for 1.8 ng/ml ergotamine, 1.5 ng/ml dihydroergotamine, 2.2 ng/ml dihydroergotoxine, 0.7 ng/ml ergotmetrine and 0.5 ng/ml methylergometrine. 4 The assay is sufficiently sensitive to permit the measurement of urine and plasma ergot alkaloid levels and it is suitable for determination in cases where a known ergot alkaloid is used.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 687503      PMCID: PMC1429444          DOI: 10.1111/j.1365-2125.1978.tb04594.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Biochemical observations on LSD-25 and Deseril.

Authors:  W DOEPFNER
Journal:  Experientia       Date:  1962-06-15

2.  The distribution and metabolism of lysergic acid diethylamide.

Authors:  J AXELROD; R O BRADY; B WITKOP; E V EVARTS
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

3.  Human plasma levels of some anti-migraine drugs.

Authors:  J Meier; E Schreier
Journal:  Headache       Date:  1976-07       Impact factor: 5.887

4.  Fluorimetric assay of ergotamine.

Authors:  W D Hooper; J M Sutherland; M J Eadie; J H Tyrer
Journal:  Anal Chim Acta       Date:  1974-03       Impact factor: 6.558

5.  Effect of caffeine on intestinal absorption of ergotamine in man.

Authors:  R Schmidt; A Fanchamps
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

6.  LSD radioimmunoassay.

Authors:  A Castro; D P Grettie; F Bartos; D Bartos
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1973-11

7.  Radioimmunoassay for lysergide (LSD) in illicit drugs and biological fluids.

Authors:  L J Loeffler; J V Pierce
Journal:  J Pharm Sci       Date:  1973-11       Impact factor: 3.534

8.  The determination of LSD in human plasma following oral administration.

Authors:  D G Upshall; D G Wailling
Journal:  Clin Chim Acta       Date:  1972-01       Impact factor: 3.786

9.  Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man.

Authors:  W H Aellig; E Nüesch
Journal:  Int J Clin Pharmacol Biopharm       Date:  1977-03

10.  Lysergic acid diethylamide: radioimmunoassay.

Authors:  A Taunton-Rigby; S E Sher; P R Kelley
Journal:  Science       Date:  1973-07-13       Impact factor: 47.728

View more
  5 in total

1.  Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing.

Authors:  S W Sanders; N Haering; H Mosberg; H Jaeger
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  Radioimmunoassay of nicergoline in biological material.

Authors:  C A Bizollon; J P Rocher; P Chevalier
Journal:  Eur J Nucl Med       Date:  1982

3.  Highly sensitive and specific radioimmunoassays for dihydroergotoxine components in plasma.

Authors:  F Collignon; P Pradelles
Journal:  Eur J Nucl Med       Date:  1984

4.  Distribution of methylergometrine in the breast milk of dogs.

Authors:  R Mäntylä
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

5.  Comparative blood level of dihydroergotoxine (DHET) after administration of two oral forms (solution & tablet): a preliminary study.

Authors:  J M Aliache; M Briot; J Couquelet; P Vigo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.